Macrogenics (MGNX)

$1.61 -0.01 (-0.62%)
Market Cap 102.48M
Revenue (ttm) 149.96M
Net Income (ttm) -66.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -44.66%
Debt to Equity Ratio 0.00
Volume 444,200
Avg Vol 1,428,258
Day's Range N/A - N/A
Shares Out 63.26M
Stochastic %K 81%
Beta 1.52
Analysts Sell
Price Target $3.40

Company Profile

MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which ha...

Industry: Biotechnology
Sector: Healthcare
Phone: 301 251 5172
Fax: 301 251 5321
Address:
9704 Medical Center Drive, Rockville, United States
FiscalTrendNavigator
FiscalTrendNavigator Dec. 27 at 8:21 AM
$MGNX Risk tolerance remains selective and tied closely to execution credibility. Competitive advantages must begin to appear in core metrics. Credible progress tends to compress risk premiums. Momentum becomes sustainable only when delivery keeps pace.
0 · Reply
Budman10
Budman10 Dec. 27 at 1:27 AM
$MGNX I guess this is all we get from MacroGenics to end the year.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 24 at 5:49 PM
$MGNX Share Price: $1.62 Contract Selected: Jul 17, 2026 $1.0 Calls Buy Zone: $0.47 – $0.58 Target Zone: $0.88 – $1.08 Potential Upside: 79% ROI Time to Expiration: 204 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
WarTimeTrader
WarTimeTrader Dec. 24 at 11:27 AM
$MGNX Forward visibility remains uneven as progress validates the underlying thesis beyond narrative appeal. Failure to demonstrate progress would likely keep valuation capped.
2 · Reply
MarketWarfare
MarketWarfare Dec. 23 at 5:33 PM
$MGNX hundreds of millions in potential milestone and royalty payments... CEO needs to announce a buyback program to prevent the stock from drifting back down to bullshit prices after every single pop. It's time to take off the gloves, Risser.
0 · Reply
PMD777
PMD777 Dec. 23 at 4:09 PM
$MGNX ask is super stacked right here…pop $1.68 they might run it a bit more
0 · Reply
SMARTR8
SMARTR8 Dec. 23 at 3:36 PM
$MGNX Doing great so far from entry at 1.35 ✅️💎 Should see a move higher soon 👀
0 · Reply
MarketWarfare
MarketWarfare Dec. 22 at 4:43 PM
$MGNX it is actually very difficult for a stock to be this much of a turd for this long. It's been a limpdick loser for 20 months now. Trades at half cash value with a robust pipeline and huge milestone/royalty payment potential. This will get back to near$10 in 2026.
1 · Reply
SMARTR8
SMARTR8 Dec. 22 at 4:28 PM
$MGNX love the strength it is showing 😏
0 · Reply
Budman10
Budman10 Dec. 22 at 3:33 PM
$MGNX this will drive some more royalty payments https://www.businesswire.com/news/home/20251221187054/en/Incyte-Japan-Announces-Approval-of-Zynyz-retifanlimab-for-the-First-Line-Treatment-of-Advanced-Anal-Cancer
0 · Reply
Latest News on MGNX
MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference

Nov 25, 2025, 4:05 PM EST - 4 weeks ago

MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference

MacroGenics Reports Third Quarter 2025 Financial Results and Provides Update on Corporate Progress

Nov 12, 2025, 4:01 PM EST - 6 weeks ago

MacroGenics Reports Third Quarter 2025 Financial Results and Provides Update on Corporate Progress

MacroGenics to Participate in the Stifel 2025 Healthcare Conference

Nov 6, 2025, 4:30 PM EST - 7 weeks ago

MacroGenics to Participate in the Stifel 2025 Healthcare Conference

MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference

Sep 2, 2025, 4:30 PM EDT - 4 months ago

MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference

MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities

Aug 14, 2025, 4:01 PM EDT - 4 months ago

MacroGenics Reports Second Quarter 2025 Financial Results and Highlights Key Strategic Priorities

MacroGenics Appoints Eric Risser as President and Chief Executive Officer

Aug 13, 2025, 4:01 PM EDT - 4 months ago

MacroGenics Appoints Eric Risser as President and Chief Executive Officer

MacroGenics: Working On That Road To Recovery

Jun 11, 2025, 6:32 PM EDT - 7 months ago

MacroGenics: Working On That Road To Recovery

MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement

Jun 10, 2025, 7:00 AM EDT - 7 months ago

MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement

MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

Jun 3, 2025, 4:30 PM EDT - 7 months ago

MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

MacroGenics Provides Update on Corporate Progress and First Quarter 2025 Financial Results

May 13, 2025, 4:01 PM EDT - 8 months ago

MacroGenics Provides Update on Corporate Progress and First Quarter 2025 Financial Results

MacroGenics Announces Date of First Quarter 2025 Financial Results

May 6, 2025, 4:30 PM EDT - 8 months ago

MacroGenics Announces Date of First Quarter 2025 Financial Results

MacroGenics to Participate in Upcoming Investor Conference

May 1, 2025, 4:30 PM EDT - 8 months ago

MacroGenics to Participate in Upcoming Investor Conference

MacroGenics, Inc. (MGNX) Q4 2024 Earnings Call Transcript

Mar 20, 2025, 7:09 PM EDT - 10 months ago

MacroGenics, Inc. (MGNX) Q4 2024 Earnings Call Transcript

MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call

Mar 6, 2025, 7:30 AM EST - 10 months ago

MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call

MacroGenics: Stacking Up A Lot Of Headwinds

Feb 27, 2025, 2:08 PM EST - 10 months ago

MacroGenics: Stacking Up A Lot Of Headwinds

MacroGenics to Participate in Upcoming Investor Conferences

Feb 27, 2025, 7:30 AM EST - 10 months ago

MacroGenics to Participate in Upcoming Investor Conferences

MacroGenics, Inc. (MGNX) Q2 2024 Earnings Call Transcript

Nov 5, 2024, 7:01 PM EST - 1 year ago

MacroGenics, Inc. (MGNX) Q2 2024 Earnings Call Transcript

MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results

Nov 5, 2024, 4:01 PM EST - 1 year ago

MacroGenics Provides Update on Corporate Progress, Third Quarter 2024 Financial Results

MacroGenics Announces Leadership Transition

Oct 30, 2024, 7:30 AM EDT - 1 year ago

MacroGenics Announces Leadership Transition

MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call

Oct 29, 2024, 4:30 PM EDT - 1 year ago

MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call

Rigrodsky Law, P.A. Is Investigating MacroGenics, Inc. On Behalf of Shareholders

Oct 25, 2024, 5:15 PM EDT - 1 year ago

Rigrodsky Law, P.A. Is Investigating MacroGenics, Inc. On Behalf of Shareholders

MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®

Oct 22, 2024, 7:30 AM EDT - 1 year ago

MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®

Shareholders of MacroGenics, Inc. Should Contact The Gross Law Firm Before September 24, 2024 to Discuss Your Rights – MGNX

Sep 24, 2024, 12:57 PM EDT - 1 year ago

Shareholders of MacroGenics, Inc. Should Contact The Gross Law Firm Before September 24, 2024 to Discuss Your Rights – MGNX

MGNX Investors Have Opportunity to Join MacroGenics, Inc. Fraud Investigation with the Schall Law Firm

Sep 24, 2024, 10:30 AM EDT - 1 year ago

MGNX Investors Have Opportunity to Join MacroGenics, Inc. Fraud Investigation with the Schall Law Firm

MacroGenics Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Encouraged To Contact The Schall Law Firm

Sep 23, 2024, 11:00 AM EDT - 1 year ago

MacroGenics Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Encouraged To Contact The Schall Law Firm

MacroGenics (MGNX) Accused of Misleading Investors Over Cancer Drug Trial - Hagens Berman

Sep 22, 2024, 11:09 AM EDT - 1 year ago

MacroGenics (MGNX) Accused of Misleading Investors Over Cancer Drug Trial - Hagens Berman

MacroGenics Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Reach Out To The Schall Law Firm

Sep 21, 2024, 11:00 AM EDT - 1 year ago

MacroGenics Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Reach Out To The Schall Law Firm

MacroGenics Inc Is Being Sued For Violating Securities Laws And Shareholders Are Urged To Contact The Schall Law Firm

Sep 19, 2024, 11:00 AM EDT - 1 year ago

MacroGenics Inc Is Being Sued For Violating Securities Laws And Shareholders Are Urged To Contact The Schall Law Firm

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics

Sep 19, 2024, 9:57 AM EDT - 1 year ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 24, 2024 in MacroGenics Lawsuit - MGNX

Sep 19, 2024, 5:45 AM EDT - 1 year ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 24, 2024 in MacroGenics Lawsuit - MGNX

MGNX Deadline: Rosen Law Firm Urges MacroGenics, Inc. (NASDAQ: MGNX) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Sep 17, 2024, 11:23 AM EDT - 1 year ago

MGNX Deadline: Rosen Law Firm Urges MacroGenics, Inc. (NASDAQ: MGNX) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Hospice Dynamix Welcomes Industry Veteran Rob Stoltz as Chief Strategy Officer

Sep 17, 2024, 11:04 AM EDT - 1 year ago

Hospice Dynamix Welcomes Industry Veteran Rob Stoltz as Chief Strategy Officer

MacroGenics Inc May Have Violated Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm About A Suit

Sep 17, 2024, 11:00 AM EDT - 1 year ago

MacroGenics Inc May Have Violated Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm About A Suit

Investor Reminder (MGNX):  Kessler Topaz Meltzer & Check, LLP Reminds MacroGenics, Inc.  Investors of September 24, 2024 Deadline

Sep 16, 2024, 12:14 PM EDT - 1 year ago

Investor Reminder (MGNX):  Kessler Topaz Meltzer & Check, LLP Reminds MacroGenics, Inc.  Investors of September 24, 2024 Deadline

FiscalTrendNavigator
FiscalTrendNavigator Dec. 27 at 8:21 AM
$MGNX Risk tolerance remains selective and tied closely to execution credibility. Competitive advantages must begin to appear in core metrics. Credible progress tends to compress risk premiums. Momentum becomes sustainable only when delivery keeps pace.
0 · Reply
Budman10
Budman10 Dec. 27 at 1:27 AM
$MGNX I guess this is all we get from MacroGenics to end the year.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 24 at 5:49 PM
$MGNX Share Price: $1.62 Contract Selected: Jul 17, 2026 $1.0 Calls Buy Zone: $0.47 – $0.58 Target Zone: $0.88 – $1.08 Potential Upside: 79% ROI Time to Expiration: 204 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
WarTimeTrader
WarTimeTrader Dec. 24 at 11:27 AM
$MGNX Forward visibility remains uneven as progress validates the underlying thesis beyond narrative appeal. Failure to demonstrate progress would likely keep valuation capped.
2 · Reply
MarketWarfare
MarketWarfare Dec. 23 at 5:33 PM
$MGNX hundreds of millions in potential milestone and royalty payments... CEO needs to announce a buyback program to prevent the stock from drifting back down to bullshit prices after every single pop. It's time to take off the gloves, Risser.
0 · Reply
PMD777
PMD777 Dec. 23 at 4:09 PM
$MGNX ask is super stacked right here…pop $1.68 they might run it a bit more
0 · Reply
SMARTR8
SMARTR8 Dec. 23 at 3:36 PM
$MGNX Doing great so far from entry at 1.35 ✅️💎 Should see a move higher soon 👀
0 · Reply
MarketWarfare
MarketWarfare Dec. 22 at 4:43 PM
$MGNX it is actually very difficult for a stock to be this much of a turd for this long. It's been a limpdick loser for 20 months now. Trades at half cash value with a robust pipeline and huge milestone/royalty payment potential. This will get back to near$10 in 2026.
1 · Reply
SMARTR8
SMARTR8 Dec. 22 at 4:28 PM
$MGNX love the strength it is showing 😏
0 · Reply
Budman10
Budman10 Dec. 22 at 3:33 PM
$MGNX this will drive some more royalty payments https://www.businesswire.com/news/home/20251221187054/en/Incyte-Japan-Announces-Approval-of-Zynyz-retifanlimab-for-the-First-Line-Treatment-of-Advanced-Anal-Cancer
0 · Reply
StockScanners
StockScanners Dec. 20 at 6:30 PM
$MGNX reached 1.66
0 · Reply
PSDL75
PSDL75 Dec. 19 at 9:09 PM
$MGNX pushed it down and then moved over 1M shares after hours...yeah sure
0 · Reply
PSDL75
PSDL75 Dec. 19 at 9:06 PM
$MGNX still - beyond belief that garbage like this flies
0 · Reply
MarketWarfare
MarketWarfare Dec. 19 at 4:42 PM
$MGNX same as always. One good day followed by weeks/months of shit.
0 · Reply
SMARTR8
SMARTR8 Dec. 19 at 4:30 PM
$ASST strong from buys at 0.783 Bottom snipe 🎯✅️ $MGNX Holding gains from 1.35 ✅️💎
0 · Reply
PSDL75
PSDL75 Dec. 18 at 7:12 PM
$MGNX would not assume this activity leads to 3% haircut
0 · Reply
SMARTR8
SMARTR8 Dec. 18 at 3:57 PM
Nobody snipes bottoms like we do. $ASST from 0.783 ✅️ pushing for 0.90+ $OPEN from 0.55 🤯 to 10+ $MGNX from 1.35 yesterday 🎯 $BKKT 8.29 before it ran to 49 ✅️ $SGBX from 2.16 to 9+ And many many more 🔥 I have order proof for ALL OF MY TRADES 🤫💎 WHAT ARE YOU WAITING FOR 😅🤝
2 · Reply
SMARTR8
SMARTR8 Dec. 18 at 2:46 PM
$MGNX Holding strong from yesterday's clean entry at 1.35 ✅️😌 $SNGX playing it tight but could make a nice move from here 👀 $BKKT so far so good from adding 9.99 yesterday 💎
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Dec. 18 at 2:37 PM
$MGNX Overnight swing working out great from out buy... $1.74 Next resistance level it's all weak 🚨🚨
1 · Reply
PSDL75
PSDL75 Dec. 18 at 12:34 PM
$MGNX documenting how they win...dark pool is prob loading this yet again..still no eyeballs
0 · Reply
PSDL75
PSDL75 Dec. 18 at 11:37 AM
$MGNX I own two names in biotech that are being purposely manipulated and if you watch the activity enough you can tell. This never trades before market and especially before 7am. Yet 4k shares have moved and there's a big ask way below market??? Let's see if someone scoops this or if they trapped some retailers...IDK after 10m shares and nearly 20% move on nothing.
0 · Reply
StockScanners
StockScanners Dec. 18 at 5:30 AM
$MGNX keep watch if this holds above 1.50
0 · Reply